|
Lyn quoted this research:
""In this group we saw the strongest prognostic power of mammaglobin levels. This is something that we didn't expect at all, since mammaglobin in the blood is a marker of metastases and therefore classically of poor prognosis. What our results mean is that low-level expression tumours are the bad ones ... because you'll miss the metastases altogether," explained Dr. Span.
"Mammaglobin expression probably has something to do with oestrogen," concluded Dr. Span, "but we are not sure what."
As a patient with ER-/PR- tumor, I don't even know if the mammoglobin expression would tell anything about my pathology. But, it is interesting for the majority of BC that is at least ER+.
That site is of high interest to me, but is very complex as the papers concern research at the MOLECULAR/GENE levels and this takes some work to wade through for any relevance I can glean.
The author of the site (more of a compendium of papers) says there are over 100 breast cancer markers at the molecular level, including some new genetic work. I did not find much about the current tests used, only that some new BC cells lines (recently discovered in pleural effusia) also show CA-15 and CEA, which means they should be detected by currrent tests.
Thanks for pointing the way to a new source of research writeups. The site is out of Belgium.
|
Threaded Mode